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Leishmania major, Trypanosoma brucei,a n dTrypanosoma cruzi (Tritryps) are unicellular protozoa that cause leishmaniasis,
sleeping sickness and Chagas’ disease, respectively. Most drugs against them were discovered through the screening of large
numbers of compounds against whole parasites. Nonhomologous isofunctional enzymes (NISEs) may present good opportunities
fortheidentiﬁcationofnewputativedrugtargetsbecause,thoughsharingthesameenzymaticactivity,theypossessdiﬀerentthree-
dimensional structures thus allowing the development of molecules against one or other isoform. From public data of the Tritryps’
genomes, we reconstructed the Genetic Information Processing Pathways (GIPPs). We then used AnEnPi to look for the presence
of these enzymes between Homo sapiens and Tritryps, as well as speciﬁc enzymes of the parasites. We identiﬁed three candidates
(ECs 3.1.11.2 and 6.1.1.-) in these pathways that may be further studied as new therapeutic targets for drug development against
these parasites.
1.Introduction
Recent estimates indicate that more than one billion people,
living in tropical and subtropical regions of developing
countries, are at the risk of contracting diseases (which are
mostly endemic at these places) caused by the protozoans
Leishmania major, Trypanosoma brucei and Trypanosoma
cruzi [1–3]. These three microorganisms, together known
as the Tritryps (family Trypanosomatidae, order Kinetoplas-
tida), also cause the death of thousands of people every
year [4]. Despite all these facts, these inﬁrmities are still
considered as neglected diseases by the health agencies [5].
The control of the diseases caused by these parasites
depends nowadays on chemicals, vaccines not being com-
mercially available so far. Besides, there is a very limited
set of pharmaceuticals available at this moment: most of
them were discovered at approximately 50 years ago, and
they also have disadvantages like high toxicity, low eﬃcacy,
or high costs; the development of resistance is also a
possibility [6–8]. However, with the recent publication of
the Tritryps’ genomes [9–11], new opportunities allowed a
better understanding of several biological processes that, up
to this point, were poorly understood or even unknown in
these organisms [7, 12].
Cellular functions are based on complex networks
of chemical reactions that interact producing observable
results. The rapid development of DNA sequencing tech-
niques provided a huge amount of information leading to
a new comprehension about the organization of cellular
processes. First, by using annotation data, genes are classiﬁed
in groups in accordance with their functions. Part of the
gene products are enzymes, proteins that catalyze cellular
reactions, making part of complex biochemical pathways. In
thepostgenomeera,thestudyoftheseprocessesisgainingan
importance, to improve the comprehension of the dynamics
and regulation of these pathways, as well as the discovery of
previously unknown steps [13, 14].
The reconstruction of biochemical pathways is consid-
ered to be one essential step in the study of cellular processes
[15]. Applications of these reconstructions may vary from2 Enzyme Research
the drawing of the biological system to the generation of
testable hypotheses about the structure and working of the
pathway and from the elucidation of complex properties not
inferred by the simple description of the individual com-
ponents to the recognition of potential drug targets against
pathogenic organisms via the identiﬁcation of essential steps
in these processes [16]. Several methods and databases
are available for the reconstruction of said pathways from
genome information; one of the main resources for this task
is the KEGG database [13, 17, 18]. One way to link the
biological processes to the genomic information is through
the EC numbers, which represent the reaction each enzyme
catalyzes. There are other types of functional classiﬁcations,
(reviewed by Ouzounis and collaborators [19]), but the EC
classiﬁcation system is certainly one of the most used by the
scientiﬁc community.
Enzymes have a high degree of speciﬁcity for their
substrates and are fundamental for any biochemical process.
They act in an organized sequence, catalyzing successive
reactions in enzymatic pathways, guaranteeing the main-
tenance of life in all organisms [20]. A particular group
of enzymes, the nonhomologous isofunctional enzymes
(NISE or analogous enzymes), executes the same function
in diﬀerent organisms, but without detectable similarity
betweentheirprimarystructuresand,possibly,betweentheir
tertiary structures as well. Once analogy is detected between
a pathogen’s enzyme and its human counterpart, it may be
possible to use this analog as a potential target for drug
development, provided it belongs to an essential biochemical
step of the pathogen. However, only a few studies have been
done to identify and annotate isofunctional nonhomologous
e n z y m e sa ss u c h[ 21–25].
Maintenance of the genome depends on the eﬃciency
and accuracy of DNA replication, as well as the repairing
systems. Through a series of complex interactions, the
genome is transcribed and in good part translated, in
order to produce the RNAs and proteins necessary for the
organism. These molecules form its structure or participate
in important reactions. For these reasons, the pathways of
DNA replication and repair, transcription and translation
(some of the Genetic Information Processing Pathways
(GIPPs)) comprise some of the most important processes
for the organism survival [26, 27]a n dw e r et h u sc h o s e na s
targets of this study.
Analyses of genomic data from L. major, T. brucei,
and T. cruzi have provided a global view of the protein-
coding genes that produce enzymes belonging to important
pathways through the identiﬁcation of several processes
in common between these parasites and other species. A
thorough examination of all this information may allow the
identiﬁcationofstepsoftheGIPPsthatareparticularlyacces-
sible to potential therapeutic interventions. New drugs may
be also developed from inhibitors of speciﬁc biochemical
processes essential to the parasite but absent in their hosts. In
this work, we employed computational methods to identify
not only speciﬁc but also nonhomologous isofunctional
enzymes in the genetic information processing pathways
of the Tritryps, enzymes that could serve as interesting
candidates for further studies aiming at their validation as
drug targets.
2.Methodology
2.1. Predicted Protein Sequences of Tritryps. The dataset of
predicted proteins of Leishmania major, Trypanosoma bru-
cei,a n dTrypanosoma cruzi was obtained from TritrypDB
(http://tritrypdb.org/tritrypdb/) as shown in Table 1.
2.2. Pathways and Enzyme Classes. As e to fp a t h w a y s
(maps) referring to the replication and repair, tran-
scription and translation processes was obtained from
KEGG (http://www.genome.jp/kegg/pathway.html#genetic).
This dataset contains a complete biochemical description
of the pathways related to genetic information processing
observed in diﬀerent organisms. Functions comprising a
certain pathway were extracted from these descriptions as a
collection of EC numbers and were used as templates for the
reconstruction of the correspondent pathways in Tritryps.
Each pathway is associated with a set of proteins, usually a
list of enzyme families with their EC numbers. KEGG has a
total of 10 maps distributed among these pathways: 6 maps
representing replication and repair; 2 maps symbolizing the
transcription, but only one with an associated EC number;
2 translation maps of which only one has an associated EC
number.
2.3. Clustering. To group homologous enzymes with the
same activity, we used the AnEnPi pipeline (http://www
.dbbm.ﬁocruz.br/AnEnPi/)[ 22], which was based on a pre-
vious study in which enzymes are considered analogous (i.e.,
with diﬀerent evolutionary origins) according to diﬀerences
in their primary structures [24]. After clustering, enzymes
within a given cluster are considered homologous, while
enzymes in diﬀerent clusters (of the same function) are con-
sidered analogous. As the cut-oﬀ parameter used in AnEnPi
is based on experimental data obtained from enzymes, other
values should probably be employed for other types of
proteins.
2.4. Protein Function Inference. Using another module of
AnEnPi, we were able to infer function of the predicted pro-
teins of trypanosomatids using the groups (or clusters)
obtained after clustering. In this module, the EC number
as-signment is based on the sequence similarity report from
aB L A S T P[ 28] procedure: predicted proteins of Tritryps
(query) against the sequences of each individual AnEnPi
cluster (subject), as described in detail in [22]. The cutoﬀ
employed for functional inference was the e-value of e−20.
2.5. Genetic Information Processing Pathways Reconstruction
and Search for NISE and Speciﬁc Enzymes. The reconstruc-
tion of the GIPPs was performed using the data inferred by
the AnEnPi pipeline. After functional inference, enzymatic
activities shared by Tritryps were disclosed using scripts
w r i t t e ni nP e r ll a n g u a g e .N I S Ea n ds p e c i ﬁ ce n z y m e sw e r e
obtained through an examination of the groups (or clusters)
produced after clustering, where sequences of Tritryps andEnzyme Research 3
Table 1: Organisms, dataset version, and number of predicted proteins of the Tritryps’ genomes.
Organisms Version Predicted Proteins
L. major http://tritrypdb.org/common/downloads/release-1.0/Lmajor/ 8406
T. brucei http://tritrypdb.org/common/downloads/release-1.0/Tbrucei/ 10123
T. cruzi http://tritrypdb.org/common/downloads/release-1.0/Tcruzi/ 23031
H. sapiens were considered analogous if allocated in diﬀerent
groups and speciﬁc if absent in H. sapiens. The PDB
database was searched for 3D structures resolved for these
enzymes.
3. Results andDiscussion
3.1. KEGG, Clustering, and Enzymatic Activity Inference. The
Tritryps’ genomes were ﬁrst sequenced in 2005 [9–11], with
all chromosomes well characterized (with the exception of
T. cruzi due to the high degree of repetitions in its genome).
However, some of the GIPPs still present gaps [29]. The
computational reconstruction of these processes, in this
work, is an attempt to obtain a better representation of them,
with emphasis on the analogous and speciﬁc enzymes. These
analogs are enzymes that, even with a small or no signiﬁcant
similarity between their primary structures (which reﬂect in
diﬀerences in their 3D structure), are able to catalyze the
same reaction [24]. For these reasons, recent eﬀorts have
been made to include this phenomenon in the functional
annotations [21, 22, 30]. Inference of function, if based
only on sequence similarity, may be insuﬃcient since they
are usually not able to detect nonhomologous isofunctional
enzymes.
Tritryps share a series of features, like the presence of
subcellular structures such as the kinetoplast and glyco-
somes. Each trypanosomatid is transmitted by a diﬀerent
vector, possessing distinct life cycles, tissue speciﬁcity, and
pathogenies in their mammal host [31, 32]. In addition, they
are considered “ancient” from an evolutionary perspective;
in fact, they present peculiar mechanisms in some of the
genetic information transmission processes. Many of these
s t i l lh a v eg a p st ob eﬁ l l e d[ 33]. In this context, we have
compared the number of enzymatic activities shared among
the three microorganisms (taking into account all pathways)
and the unique activities based on the results obtained after
clustering (Figure 1). It may be worth noticing that some
activities found have the same isoform (or, more precisely,
analogform)inthethreemicroorganisms;thismayserveasa
basis (ideally and depending on several other factors) for one
unique drug for the three pathogens or (much more likely) a
family of related/similar molecules as drugs.
KEGG has its own annotation protocol, which to our
knowledge is not described in detail anywhere; only its
general lines are known [17, 34]. We opted to make a
functional inference from all the predicted proteins of
Tritryps, in order to have a uniﬁed and comparable data.
For this, we performed a BLASTP of the available predicted
proteins in the TriTrypDB against the obtained clusters.
From this it was possible to infer functions not detected by
53
13
11
26
435
28
50
L. major
T. cruzi T. brucei
Figure 1: Venn diagram of shared enzymatic activities between the
Tritryps. Yellow: L. major unique ECs; red: T. cruzi unique ECs;
blue: T. brucei unique ECs; orange: between T. cruzi and T. brucei;
green: between L. major and T. brucei; purple: between T. cruzi and
L. major; gray: between all Tritryps.
KEGG, in almost all pathways studied. Even using a very
restrictive cut-oﬀ (e-value < 10−20), more enzymes were
identiﬁed (data not shown), indicating the validity of this
approach. In fact, even after using more restrictive e-values,
like 10−40 or 10−80, results did not diﬀer for several ECs (data
not shown).With theseinformation, someoftheGIPPswere
reconstructed. The description of the enzymatic activities
found by AnEnPi for each Tritryp is listed in Table 2.
3.2. Computational Reconstruction of the GIPPs. Figure 2
displaysthecomputationalreconstructionoftheGIPPsusing
the map representing the aminoacyl-tRNA biosynthesis
(map 00970) as an example. The other 7 maps, as well as
the tables with the description of the enzymes highlighted
in each map, are available in the Supplementary Material
available online at doi:10.4061/2011/543912. In this map, all
enzymatic activities detected by KEGG were also identiﬁed
by AnEnPi for the Tritryps, with the exception of SepRS
(EC 6.1.1.27). This enzyme participates of the alternative
formation of Cys-tRNACys linking O-phosphoserine, a pre-
cursor of the aminoacid cysteine, to tRNACys. Then SepCysS
(Sep-tRNA:Cys-tRNA synthetase—EC 2.5.1.73) converts O-
phosphoseryl-tRNACys in cysteinyl-tRNACys. This alterna-
tive formation of Cys-tRNACys has been only detected
in methanogenic archaea so far, where in some species
the enzyme cysteinyl-tRNA synthetase (EC 6.1.1.16), which
catalyzes the direct production of Cys-tRNACys, is lacking
[35, 36]. However, we could not identify the second enzyme
which completes the alternative formation of Cys-tRNACys,4 Enzyme Research
Table 2: List of additional ECs found in each process from GIPPs.
Pathway number Map description T. cruzi T. brucei L. major EC description
Translation
Map00970 Aminoacyl-tRNA biosynthesis
2.1.2.9 a b Methionyl-tRNA
formyltransferase
6.1.1.- 6.1.1.- 6.1.1.- O-phosphoseryl-tRNA
synthetase
Replication and repair
Map03030 DNA replication 3.6.1.- 3.6.1.- 3.6.1.-
Hydrolases acting in
phosphorus-containing
anhydrides
Map03410 Base excision repair 3.1.-.- 3.1.-.- 3.1.-.- Hydrolases acting on ester bonds
3.1.11.2 3.1.11.2 3.1.11.2 Exodeoxyribonuclease III
Map03420 Nucleotide excision repair 2.7.11.22 2.7.11.22 2.7.11.22 Cyclin-dependent kinase
Map03430 Mismatch repair 3.6.1.- 3.6.1.- 3.6.1.-
Hydrolases acting in
phosphorus-containing
anhydrides
Map03440 Homologous recombination 3.1.-.- 3.1.-.- 3.1.-.- Hydrolases acting on ester bonds
Map03450 Nonhomologous end-joining
2.7.11.1 2.7.11.1 2.7.11.1 Nonspeciﬁc serine/threonine
protein kinase
2.7.7.7 2.7.7.7 2.7.7.7 DNA-directed DNA polymerase
3.1.-.- 3.1.-.- 3.1.-.- Hydrolases acting on ester bonds
4.2.99.- 4.2.99.- 4.2.99.- Other carbon-oxygen lyases
aPreviously identiﬁed by KEGG as entry “Tb11.01.7110”.
bPreviously identiﬁed by KEGG as entry “LmjF32.2240”.
SepCysS.Onepossibleexplanationisthat,whilethispathway
is essential to archaea (that do not possess the direct pathway
for Cys-tRNACys formation), it is not for the Tritryps. Or
yet, this enzyme has a particular gene sequence or structure,
not yet examined experimentally.
The enzymatic activity represented by EC 2.1.2.9 (me-
thyonyl-tRNA formyltransferase), which is also part of the
aminoacyl-tRNA biosynthesis map, was identiﬁed by KEGG
only for L. major and T. brucei; this activity was identiﬁed
by AnEnPi in T. cruzi. This enzyme is responsible for
adding the formyl radical to tRNAMet, which serves as the
tRNA initiator of the polypeptide chain during translation
in bacteria. It has the same function in eukaryotes, acting
in mitochondria [27]. Since mitochondria have a bacterial
evolutionary origin, their translational apparatus follow the
bacterial model. Genomic data of the organisms studied in
this work consists mainly of nuclear DNA. The occurrence
of this enzyme in nuclear DNA is in agreement with the
observed absence of tRNA genes in the mitochondrial DNA
of Tritryps (kDNA), which are imported from the cytoplasm
[37–39].
DNA in cells is often under attack by mutagens, oxygen
radicals, and ionizing radiation, and even cellular processes
can create mutagenic and cytotoxic DNA lesions which can
be lethal to the cell. Organisms possess broad mechanisms
of DNA repair to ﬁx damaged DNA and in order to
keep viability and genomic stability [40]. In this context,
we identiﬁed four enzymatic activities with complete EC
numbers (four digits) from three DNA repair pathways: base
excision repair (EC 3.1.11.2), nucleotide excision repair (EC
2.7.11.22), and nonhomologous end-joining (EC 2.7.11.1
and EC 2.7.7.7) (Table 2).
The enzyme exodeoxyribonuclease III (3.1.11.2—Fig-
ure S3 and Table S4) is responsible to catalyze the deg-
radation of double-stranded DNA acting progressively in
a3   to 5  direction, releasing 5 -phosphomononucleotides
on base excision repair (BER) pathway. The enzymes of
this pathway are conserved from bacteria to man, but
mammalian enzymes frequently add in, within a larger
structural framework, the catalytic core domains of bacterial
enzymes [40, 41].
Cyclin-dependent kinase (EC 2.7.11.22) from nucleotide
excision repair (NER) is linked to a complex called holo-
TFIIH complex (Figure S4 and Table S5). This is a multipro-
tein complex required not only for transcription but also for
nucleotide excision repair. This enzyme is responsible for the
phosphorylation of the carboxy-terminal domain (CTD) of
RNA polymerase II in the absence of promoter opening [42].
Nonhomologous end-joining (NHEJ) is a kind ofrecom-
bination that links the ends from broken nonhomologous
chromosomes. The core NHEJ components are conserved
from yeast to mammals and consist of the XRCC4/DNA-
Ligase IV complex and the Ku70/Ku80 heterodimer. Both
protect exposed DNA of degradation. First, the catalytic
subunit, formed by DN-APKcs (EC 2.7.11.1—nonspeciﬁc
serine/threonine protein kinase) and Artemis, is recruited.
The DNA-PKcs phosphorylate the Ku heterodimer and also
the Artemis complex which corresponds to a nuclease.
Interactions between such protein complexes approximateEnzyme Research 5
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Figure 2: Aminoacyl-tRNA biosynthesis map. Gray boxes represent enzymes identiﬁed by AnEnPi for the Tritryps. White boxes are those
that were not identiﬁed by KEGG neither by AnEnPi. Blue star: ECs identiﬁed by KEGG for the Tritryps. Red star: ECs identiﬁed by KEGG
for L. major and T. brucei. Modiﬁed from http://www.genome.jp/kegg/pathway/map/map00970.html.
thechromosomalends.Anotherenzymewhoseparticipation
is essential in such complex is the DNA-directed DNA
polymerase(EC2.7.7.7)whichﬁllsinthegapswhentheends
are joined (Figure S6 and Table S7) [43–45].
3.3. Speciﬁc Enzymes and Functional Analogs between the
Tritryps and Homosapiens as Potential Therapeutic Targets.
Data produced by the genome projects of the Tritryps
allowed researchers to establish new strategies to solve the
problems caused by these diseases, which aﬀect a great
percentage of the world’s population [46]. The majority of
the proposed drugs so far were discovered many years ago
and several of them are toxic, have low eﬃcacy, and the
risk of resistance development is also a possibility [7]. To
search for functional analogs that could serve as potential
candidatesasdrugtargets,welookedforthepresenceofthese
enzymes between the Tritryps and H. sapiens, by comparing
their primary structures. One case meeting these criteria was
identiﬁed: the exodeoxyribonuclease III (EC 3.1.11.2) from
BER pathway.
Exodeoxyribonuclease III is an exonuclease that cleaves
the 5  side of an AP (apurinic/apyrimidinic) site, acting in6 Enzyme Research
the repair pathway by base excision [47]. In Escherichia coli
this enzyme is a DNA-modifying enzyme, very frequently
used in molecular biology, which degrades single-stranded
DNA as a substrate. We searched for more information
about the inhibitors of this enzyme in the BRENDA
database (http://www.brenda-enzymes.org/). According to
Hoheisel [48], double-stranded DNA was found to be a
competitive inhibitor of the enzyme activity. Other known
inhibitors are EDTA (Ethylenediamine tetraacetic acid) [49],
Mn2+ at concentrations above 5mM [50], NaCl [48], p-
chloromercuribenzoate [51], PNA (Peptide nucleic acids)
[52], and ZnCl2 [51, 53].
Apurinic/apyrimidinic sites are very toxic to cells if not
repaired. These sites can be generated by normal aerobic
metabolism, UV light, or H2O2. Exodeoxyribonuclease III
(xthA gene) can be considered a relevant target for Tritryps
because it plays an essential role in the BER pathway, a key
repair system to neutralize DNA oxidative stress. E. coli xthA
mutant strains hold a residual AP endonucleolytic activity
due to the protein encoded by the nfo gene, the endonuclease
IV (Endo IV). Mutants of nfo or xthA genes are generally
sensitive to oxidizing agents [54]. Some authors pointed out
that Exo III is involved in the protection of E.coli cells against
the toxic eﬀects of UV light, H2O2 [54–57] and is necessary
to induce DNA damage repair [58].
Moreover, we have also identiﬁed a potential therapeutic
target unique for L. major, the DNA 3-methyladenine gly-
cosilaseII(EC3.2.2.21).Thisenzymeconsistsinaglycosilase
which breaks the bond between alkylated nitrogenated bases
and their phosphate group, removing it and leaving an AP
site [59, 60].
O-phosphoseryl-tRNA synthetase (EC 6.1.1.-), assigned
to the Aminoacyl-tRNA biosynthesis map, was identiﬁed as a
speciﬁc activity in Tritryps when compared with H. sapiens.
This enzyme, today designated by the EC number 6.1.1.27,
catalyzes the alternative formation of Cys-tRNACys [61], as
previously described.
The TDR Targets database (http://tdrtargets.org/) inte-
grates genetic and biochemical information to pharmacolog-
ical data, all related to (primarily) tropical pathogens. The
main objective is to assist the search for targets using an
integrative platform [62]. None of the two ECs identiﬁed
(EC 3.1.11.2 and EC 6.1.1.27) had any information related to
the Tritryps in this database. This suggests that the approach
used in this work may increase the number of possible drug
targets. However, exodeoxyribonuclease III (EC 3.1.11.2) is
assigned as a potential target in this database, but for other
organisms. In addition, DNA 3-methyladenine glycosilase
II (EC 3.2.2.21), which in this work was identiﬁed only in
L. major,isalsoassignedasapotentialtarget(again,forother
organisms, not for Leishmania).
None of the enzymatic functions disclosed in this work
has a resolved 3D structure in the PDB database for any of
the Tritryps. Use of resolved 3D structures, as well as other
types of information like functional studies, is paramount to
advance research on these enzymes, to ensure that they are
indeed possible targets for drug development. In the present
work, we have studied only a part of the pathways assigned
to the GIPPs in KEGG. We have left aside other important
pathways such as those related to protein folding, sorting,
and degradation, consisting in about 7 additional maps with
several enzymes. Moreover, KEGG has already integrated
more information and maps to the GIPPs, since it is updated
weekly.Inthefuture,athoroughreevaluationoftheavailable
data may disclose new cases of analogy and/or new speciﬁc
enzymes.
The utilization of computers is constantly increasing in
the ﬁeld of drug discovery, because of the great potential
in speeding up the identiﬁcation of suitable targets and
useful compounds and also (arguably the most important
feature) in reducing costs. In this work, the development and
utilization of computational methods allowed us to identify,
in the genetic information processing pathways of Tritryps,
speciﬁc and nonhomologous isofunctional enzymes (NISE).
The identiﬁcation of NISE allowed the construction of an
enriched list of proteins (containing not only organism-
speciﬁcenzymes)thatmustbefurtherstudiedtobevalidated
as drug targets. Among these studies, we can cite (i) the
obtention of crystals of the selected proteins to allow the
construction of 3D models by molecular modeling, (ii)
molecular dynamics and docking studies, to obtain a reﬁned
representation of their structure, including movement and
possibly other interacting molecules as well, and (iii) a series
of functional studies to determine their kinetics, expression
patterns, stability, essentiality, and so forth.
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